Medical Technology Stock Letter

BioInvest.com is the web home of the Medical Technology Stock Letter, an industry leading newsletter covering the biotech sector for almost thirty years.  Seeking information on FDA Approvals, Biotech Mergers & Acquisitions, Stock Picks, Long Investments and the occassional Short Sale?  Trying to stay on the cutting edge of scientific developments so you can stay ahead of the Markets? 

The Medical Technology Stock Letter is the source for Biotechnology news and investing advice.  Forget the pundits and the trends.  Here you find only experienced insight and the details that Wall Street doesn't want you to know.

Request a Free Issue then go to the Newsletter page to find out what's new at MTSL.

Subscribers, click here to log in or go directly to the Subscriber area.

Search BioInvest.com
Loading
Latest News from Yahoo! Finance

RXi Pharmaceuticals Corporation (RXII)

DateFriday, July 9, 2010 at 12:35PM

RXi Pharmaceuticals Corporation (RXII)

Public

 

Address:

60 Prescott St

Worcester, MA  01605

United States

Phone:  508-767-3861

Approximate Number of Employees:  28

 

Drugs/Technologies: 

Pipeline/Product Website:  http://www.rxipharma.com/new_ther_platform.html

Disease Areas/Keywords:  RNA interference (RNAi), Neurological Disorders, Metabolic, Oncology

 

Website:  http://www.rxipharma.com/main_page.html

IR/PR Website:  http://www.rxipharma.com/investor_relations.html

Jobs Website:  http://www.rxipharma.com/careers.html

Wikipedia: 

 

News and Financial information from Yahoo! Finance:


AuthorAdministrator | Comments Off |

PrintView Printer Friendly Version

EmailEmail Article to Friend